Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Short term Debt (2011 - 2026)

Mimedx recorded quarterly Short term Debt of $1.5 million in Q1 2026, little changed quarter-over-quarter from $1.5 million in Q4 2025, and up 33.33% year-over-year from $1.1 million in Q1 2025.

Mimedx's Short term Debt history runs 10 years deep, the most recent figure standing at $1.5 million for Q1 2026.

  • In Q1 2026, Short term Debt rose 33.33% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 33.33% YoY), while the FY2025 annual figure was $1.5 million, up 50.0% from the prior year.
  • Short term Debt came in at $1.5 million for Q1 2026 at Mimedx, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.2 million in Q2 2024 to a low of $1.0 million in Q4 2023.
  • A 4-year average of $1.3 million and a median of $1.2 million in 2025 frame the typical range for Short term Debt.
  • On a YoY basis, Short term Debt climbed as much as 50.0% in 2025 and fell as far as 43.18% in 2025.
  • Mimedx's Short term Debt stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then soared by 50.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods registered $1.5 million, $1.5 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.50 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 1.38 Mn
Jun 30, 2025 1.25 Mn
Mar 31, 2025 1.13 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 1.00 Mn
Jun 30, 2024 2.20 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 1.00 Mn
Jun 30, 2020 3.75 Mn
Mar 31, 2020 3.75 Mn
Dec 31, 2019 3.75 Mn
Sep 30, 2019 3.75 Mn
Jun 30, 2019 3.75 Mn
Jun 30, 2017 17.57 Mn
Mar 31, 2017 8.74 Mn
Dec 31, 2016 8.26 Mn
Sep 30, 2016 9.64 Mn
Jun 30, 2016 9.64 Mn
Jun 30, 2012 1.07 Mn
Mar 31, 2012 969,680.00
Dec 31, 2011 1.13 Mn